162 related articles for article (PubMed ID: 7892186)
1. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture.
Morré DJ; Chueh PJ; Morré DM
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1831-5. PubMed ID: 7892186
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines.
Morré DJ; Sun E; Geilen C; Wu LY; de Cabo R; Krasagakis K; Orfanos CE; Morré DM
Eur J Cancer; 1996 Oct; 32A(11):1995-2003. PubMed ID: 8943687
[TBL] [Abstract][Full Text] [Related]
3. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture.
Morré DJ; Bridge A; Wu LY; Morré DM
Biochem Pharmacol; 2000 Oct; 60(7):937-46. PubMed ID: 10974202
[TBL] [Abstract][Full Text] [Related]
4. Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells.
Wilkinson F; Kim C; Cho N; Chueh PJ; Leslie S; Moya-Camarena S; Wu LY; Morré DM; Morré DJ
Arch Biochem Biophys; 1996 Dec; 336(2):275-82. PubMed ID: 8954575
[TBL] [Abstract][Full Text] [Related]
5. A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients.
Chueh PJ; Morré DJ; Wilkinson FE; Gibson J; Morré DM
Arch Biochem Biophys; 1997 Jun; 342(1):38-47. PubMed ID: 9185612
[TBL] [Abstract][Full Text] [Related]
6. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients.
Morré DJ; Caldwell S; Mayorga A; Wu LY; Morré DM
Arch Biochem Biophys; 1997 Jun; 342(2):224-30. PubMed ID: 9186482
[TBL] [Abstract][Full Text] [Related]
7. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of capsaicin on HeLa cells is not mediated by intracellular calcium mobilization.
Takahata K; Chen X; Monobe K; Tada M
Life Sci; 1999; 64(13):PL165-71. PubMed ID: 10210280
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids.
Dai S; Morré DJ; Geilen CC; Almond-Roesler B; Orfanos CE; Morré DM
Mol Cell Biochem; 1997 Jan; 166(1-2):101-9. PubMed ID: 9046026
[TBL] [Abstract][Full Text] [Related]
10. A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells.
del Castillo-Olivares A; Yantiri F; Chueh PJ; Wang S; Sweeting M; Sedlak D; Morré DM; Burgess J; Morré DJ
Arch Biochem Biophys; 1998 Oct; 358(1):125-40. PubMed ID: 9750173
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
12. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?
Morré DJ; Kim C; Paulik M; Morré DM; Faulk WP
J Bioenerg Biomembr; 1997 Jun; 29(3):269-80. PubMed ID: 9298712
[TBL] [Abstract][Full Text] [Related]
13. Differential response of the NADH oxidase of plasma membranes of rat liver and hepatoma and HeLa cells to thiol reagents.
Morré DJ; Morré DM
J Bioenerg Biomembr; 1995 Feb; 27(1):137-44. PubMed ID: 7629045
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes.
Morré DJ; de Cabo R; Farley C; Oberlies NH; McLaughlin JL
Life Sci; 1995; 56(5):343-8. PubMed ID: 7837933
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid and calcitriol inhibition of growth and NADH oxidase of normal and immortalized human keratinocytes.
Morré DJ; Morré DM; Paulik M; Batova A; Broome AM; Pirisi L; Creek KE
Biochim Biophys Acta; 1992 Apr; 1134(3):217-22. PubMed ID: 1558845
[TBL] [Abstract][Full Text] [Related]
16. Cell-surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase.
Berridge MV; Tan AS
Antioxid Redox Signal; 2000; 2(2):277-88. PubMed ID: 11229532
[TBL] [Abstract][Full Text] [Related]
17. Mode of action of the anticancer quassinoids--inhibition of the plasma membrane NADH oxidase.
Morré DJ; Grieco PA; Morré DM
Life Sci; 1998; 63(7):595-604. PubMed ID: 9718085
[TBL] [Abstract][Full Text] [Related]
18. Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients.
Kim C; MacKellar WC; Cho NM; Byrn SR; Morré DJ
Biochim Biophys Acta; 1997 Mar; 1324(2):171-81. PubMed ID: 9092704
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1997 Feb; 1355(2):114-20. PubMed ID: 9042331
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
